Monday, June 6, 2011

DSM-IV Complete Code List of Mental Disorders

In the list below you can see all known mental disorders and the attributed code.
The fifth digit denotes severity and level for “major depressive” and “Manic” episodes where: .01- mild; .02- moderate; .03- severe, but without psychotic features; .04- severe with psychotic features; .05- partially remissioned; .06- fully remissioned; .00- unspecified
Code Mental Disorder
290.0 Dementia of the Alzheimer’s Type, With Late Onset, Uncomplicated
290.10 Dementia due to Pick’s Disease
290.10 Dementia due to Creutzfeld-Jacob disease
290.10 Dementia of the Alzheimer’s Type, With Early Onset, Uncomplicated
290.11 Dementia of the Alzheimer’s Type, With Early Onset, With Delirium
290.12 Dementia of the Alzheimer’s Type, With Early Onset, With Delusions
290.13 Dementia of the Alzheimer’s Type, With Early Onset, With Depressed Mood
290.20 Dementia of the Alzheimer’s Type, With Late Onset, With Delusions
290.21 Dementia of the Alzheimer’s Type, With Late Onset, With Depressed Mood
290.3 Dementia of the Alzheimer’s Type, With Late Onset, With Delirium
290.40 Vascular Dementia, Uncomplicated
290.41 Vascular Dementia, With Delirium
290.42 Vascular Dementia, With Delusions
290.43 Vascular Dementia, With Depressed Mood

291.0 Alcohol Intoxication Delirium
291.0 Alcohol Withdrawal Delirium
291.1 Alcohol-Induced Persisting Amnestic Disorder
291.2 Alcohol-Induced Persisting Dementia
291.3 Alcohol-Induced Psychotic Disorder With Hallucinations
291.5 Alcohol-Induced Psychotic Disorder With Delusions
291.8 Alcohol Withdrawal
291.8 Alcohol-Induced Mood Disorder
291.8 Alcohol-Induced Anxiety Disorder
291.8 Alcohol-Induced Sleep Disorder
291.8 Alcohol-Induced Sexual Dysfunction
291.9 Alcohol-Related Disorder NOS

292.0 Substance [Amphetamine, Cocaine, Nicotine, Opioid, Sedative*, Other (or Unknown)] Withdrawal
292.11 Substance [Amphetamine, Cannabis, Cocaine, Hallucinogen, Inhalant, Opioid, Phencyclidine, Sedative*, Other (or Unknown)]-Induced Psychotic Disorder, With Delusions
292.12 Substance [Amphetamine, Cannabis, Cocaine, Hallucinogen, Inhalant, Opioid, Phencyclidine, Sedative*, Other (or Unknown)]-Induced Psychotic Disorder, With Hallucinations
292.81 Substance [Sedative*, Other (or Unknown)] Withdrawal Delirium
292.81 Substance [Amphetamine, Cannabis, Cocaine, Hallucinogen, Inhalant, Opioid, Phencyclidine, Sedative*, Other (or Unknown)] Intoxication Delirium
292.82 Substance [Inhalant, Sedative*, Other (or Unknown)]-Induced Persisting Dementia
292.83 Substance [Sedative*, Other (or Unknown)]-Induced Persisting Amnestic Disorder
292.84 Substance [Amphetamine, Cocaine, Hallucinogen, Inhalant, Opioid, Phencyclidine, Sedative*, Other (or Unknown)]-Induced Mood Disorder
292.89 Substance [Amphetamine, Caffeine, Cannabis, Cocaine, Hallucinogen, Inhalant, Phencyclidine, Sedative*, Other (or Unknown)]-Induced Anxiety Disorder
292.89 Substance [Amphetamine, Caffeine, Cocaine, Opioid, Sedative*, Other (or Unknown)]-Induced Sleep Disorder
292.89 Substance [Amphetamine, Cocaine, Opioid, Sedative*, Other (or Unknown)]-Induced Sexual Dysfunction
292.89 Hallucinogen Persisting Perception Disorder (Flashbacks)
292.89 Substance [Amphetamine, Cannabis, Cocaine, Hallucinogen, Inhalant, Opioid, Phencyclidine, Sedative*, Other (or Unknown)] Intoxication
292.9 Substance [Amphetamine, Caffeine, Cannabis, Cocaine, Hallucinogen, Inhalant, Nicotine, Opioid, Phencyclidine, Sedative*, Other (or Unknown)]-Related Disorder NOS

293.0 Delirium Due to General Medical Condition
293.81 Psychotic Disorder Due to [General Medical Condition], With Delusions
293.82 Psychotic Disorder Due to [General Medical Condition], With Hallucinations
293.83 Mood Disorder Due to General Medical Condition
293.89 Anxiety Disorder Due to General Medical Condition
293.89 Catatonic Disorder Due to General Medical Condition
293.9 Mental Disorder due to General Medical Condition

294.0 Amnestic Disorder Due to General Medical Condition
294.1 Dementia Due to Parkinson’s Disease
294.1 Dementia Due to Head Trauma
294.1 Dementia Due to Huntington’s Disease
294.1 Dementia Due to [Other General Medical Condition]
294.8 Dementia NOS or Amnestic Disorder NOS
294.9 Dementia Due to HIV Disease
294.9 Cognitive Disorder NOS

295.10 Schizophrenia, Disorganized Type
295.20 Schizophrenia, Catatonic Type
295.30 Schizophrenia, Paranoid Type
295.40 Schizophreniform Disorder
295.60 Schizophrenia, Residual Type
295.70 Schizoaffective Disorder
295.90 Schizophrenia Undifferentiated Type
296.0x Bipolar I Disorder Single Manic Episode
296.2x Major Depressive Disorder Single Episode
296.3x Major Depressive Disorder Recurrent
296.40 Bipolar I Disorder Most Recent Episode Hypomanic
296.4x Bipolar I Disorder Most Recent Episode Manic
296.5x Bipolar I Disorder Most Recent Episode Depressed
296.6x Bipolar I Disorder Most Recent Episode Mixed
296.7 Bipolar I Disorder, Most recent episode Unspecified
296.80 Bipolar Disorder NOS
296.89 Bipolar II Disorder
296.90 Mood Disorder NOS

297.1 Delusional Disorder
297.3 Shared Psychotic Disorder

298.8 Brief Psychotic Disorder
298.9 Psychotic Disorder NOS

299.00 Autistic Disorder
299.10 Childhood Disintegrative Disorder
299.80 Rett’s Disorder
299.80 Asperger’s Disorder
299.80 Pervasive Developmental Disorder NOS

300.00 Anxiety Disorder NOS
300.01 Panic Disorder Without Agoraphobia
300.02 Generalized Anxiety Disorder
300.11 Conversion Disorder
300.12 Dissociative Amnesia
300.13 Dissociative Fugue
300.14 Dissociative Identity Disorder
300.15 Dissociative Disorder NOS
300.16 Factitious Disorder With Predominantly Psychological Signs and Symptoms
300.19 Factitious Disorder NOS
300.19 Factitious Disorder With Combined Psychological and Physical Signs and Symptoms
300.19 Factitious Disorder With Predominantly Physical Signs and Symptoms
300.21 Panic Disorder With Agoraphobia
300.22 Agoraphobia Without History of Panic Disorder
300.23 Social Phobia
300.29 Specific Phobia
300.3 Obsessive-Compulsive Disorder
300.4 Dysthymic Disorder
300.6 Depersonalization Disorder
300.7 Body Dysmorphic Disorder
300.7 Hypochondriasis
300.81 Somatization Disorder
300.81 Undifferentiated Somatoform Disorder
300.81 Somatoform Disorder NOS
300.9 Unspecified Mental Disorder (nonpsychotic)

301.0 Paranoid Personality Disorder
301.13 Cyclothymic Disorder
301.20 Schizoid Personality Disorder
301.22 Schizotypal Personality Disorder
301.4 Obsessive-Compulsive Personality Disorder
301.50 Histrionic Personality Disorder
301.6 Dependent Personality Disorder
301.7 Antisocial Personality Disorder
301.81 Narcissistic Personality Disorder
301.82 Avoidant Personality Disorder
301.83 Borderline Personality Disorder
301.9 Personality Disorder NOS

302.2 Pedophilia
302.3 Transvestic Fetishism
302.4 Exhibitionism
302.6 Gender Identity Disorder NOS
302.6 Gender Identity Disorder in Children or Gender Identity Disorder NOS
302.70 Sexual Dysfunction NOS
302.71 Hypoactive Sexual Desire Disorder
302.72 Female Sexual Arousal Disorder
302.72 Male Erectile Disorder
302.73 Female Orgasmic Disorder
302.74 Male Orgasmic Disorder
302.75 Premature Ejaculation
302.76 Dyspareunia (Not Due to a General Medical Condition)
302.79 Sexual Aversion Disorder
302.81 Fetishism
302.82 Voyeurism
302.83 Sexual Masochism
302.84 Sexual Sadism
302.85 Gender Identity Disorder in Adolescents or Adults
302.89 Frotteurism
302.9 Sexual Disorder NOS
302.9 Paraphilia NOS

303.00 Alcohol Intoxication
303.90 Alcohol Dependence

304.00 Opioid Dependence
304.10 Sedative, Hypnotic, or Anxiolytic Dependence
304.20 Cocaine Dependence
304.30 Cannabis Dependence
304.40 Amphetamine Dependence
304.50 Hallucinogen Dependence
304.60 Inhalant Dependence
304.80 Polysubstance Dependence
304.90 Phencyclidine Dependence
304.90 Other (or Unknown) Substance Dependence

305.00 Alcohol Abuse
305.10 Nicotine Dependence
305.20 Cannabis Abuse
305.30 Hallucinogen Abuse
305.40 Sedative, Hypnotic, or Anxiolytic Abuse
305.50 Opioid Abuse
305.60 Cocaine Abuse
305.70 Amphetamine Abuse
305.90 Phencyclidine Abuse
305.90 Inhalant Abuse
305.90 Other (or Unknown) Substance Abuse

306.51 Vaginismus (Not Due to a General Medical Condition)

307.0 Stuttering
307.1 Anorexia Nervosa
307.20 Tic Disorder NOS
307.21 Transient Tic Disorder
307.22 Chronic Motor or Vocal Tic Disorder
307.23 Tourette’s Disorder
307.3 Stereotypic Movement Disorder
307.42 Primary Insomnia
307.42 Insomnia Related to [General Medical Condition]
307.44 Primary Hypersomnia
307.44 Hypersomnia Related to [General Medical Condition]
307.45 Circadian Rhythm Sleep Disorder
307.46 Sleep Terror Disorder
307.46 Sleepwalking Disorder
307.47 Dyssomnia NOS
307.47 Nightmare Disorder
307.47 Parasomnia NOS
307.50 Eating Disorder NOS
307.51 Bulimia Nervosa
307.52 Pica
307.53 Rumination Disorder
307.59 Feeding Disorder of Infancy or Early Childhood
307.6 Enuresis (Not Due to a General Medical Condition)
307.7 Encopresis Without Constipation and Overflow Incontinence
307.80 Pain Disorder Associated With Psychological Factors
307.89 Pain Disorder Associated With Both Psychological Factors and a General Medical Condition
307.9 Communication Disorder NOS

308.3 Acute Stress Disorder

309.0 Adjustment Disorder With Depressed Mood
309.21 Separation Anxiety Disorder
309.24 Adjustment Disorder With Anxiety
309.28 Adjustment Disorder With Mixed Anxiety and Depressed Mood
309.3 Adjustment Disorder With Disturbance of Conduct
309.4 Adjustment Disorder With Mixed Disturbance of Emotions and Conduct
309.81 Posttraumatic Stress Disorder
309.9 Adjustment Disorder Unspecified

310.1 Personality Disorder Due to General Medical Condition

311 Depressive Disorder NOS

312.30 Impulse-Control Disorder NOS
312.31 Pathological Gambling
312.32 Kleptomania
312.33 Pyromania
312.34 Intermittent Explosive Disorder
312.39 Trichotillomania
312.81 Conduct Disorder

313.81 Oppositional Defiant Disorder
312.9 Disruptive Behavior Disorder NOS
313.23 Selective Mutism
313.81 Oppositional Defiant Disorder
313.82 Identity Problem
313.89 Reactive Attachment Disorder of Infancy or Early Childhood
313.9 Disorder of Infancy, Childhood, or Adolescence NOS

314.00 Attention-Deficit/Hyperactivity Disorder Predominantly Inattentive Type
314.01 Attention-Deficit/Hyperactivity Disorder Combined Type
314.01 Attention-Deficit/Hyperactivity Disorder Predominantly hyperactive-Impulsive Type
314.9 Attention-Deficit/Hyperactivity Disorder NOS

315.00 Reading Disorder
315.1 Mathematics Disorder
315.2 Disorder of Written Expression
315.31 Expressive Language Disorder
315.31 Mixed Receptive-Expressive Language Disorder
315.39 Phonological Disorder
315.4 Developmental Coordination Disorder
315.9 Learning Disorder NOS

316 Psychological Factors Affecting Medical Condition

317 Mild mental retardation

318.0 Moderate Mental Retardation
318.1 Severe Mental Retardation
318.2 Profound Mental Retardation

319 Mental Retardation, Severity Unspecified

332.1 Neuroleptic-Induced Parkinsonism
333.1 Medication-Induced Postural Tremor
333.7 Neuroleptic-Induced Acute Dystonia
333.82 Neuroleptic-Induced Tardive Dyskinesia
333.90 Medication-Induced Movement Disorder NOS
333.92 Neuroleptic Malignant Syndrome
333.99 Neuroleptic-Induced Acute Akathisia

347 Narcolepsy

607.84 Male Erectile Disorder Due to [General Medical Condition]
608.89 Male Dyspareunia Due to [General Medical Condition]
608.89 Other Male Sexual Dysfunction Due to [General Medical Condition]
608.89 Male Hypoactive Sexual Desire Disorder Due to [General Medical Condition]

625.0 Female Dyspareunia Due to [General Medical Condition]
625.8 Other Female Sexual Dysfunction Due to [General Medical Condition]
625.8 Female Hypoactive Sexual Desire Disorder Due to [General Medical Condition]

780.09 Delirium NOS
780.52 Sleep Disorder Due to [General Medical Condition], Insomnia Type
780.54 Sleep Disorder Due to [General Medical Condition], Hypersomnia Type
780.59 Sleep Disorder Due to [General Medical Condition], Parasomnia
780.59 Breathing-Related Sleep Disorder
780.59 Sleep Disorder Due to [General Medical Condition], Mixed Type
780.9 Age-Related Cognitive Decline

787.6 Encopresis, With Constipation and Overflow Incontinence

799.9 Diagnosis or Condition Deferred on Axis I or Diagnosis Deferred on Axis II

995.2 Adverse Effects of Medication NOS
995.5 Neglect of Child (if focus of attention is on victim)
995.5 Sexual abuse of child (if focus of attention is on victim)
995.5 Physical abuse of child (if focus of attention is on victim)
995.81 Physical abuse of adult (if focus of attention is on victim)
995.81 Sexual abuse of adult (if focus of attention is on victim)

V15.81 Noncompliance With Treatment
V61.1 Partner Relational Problem
V61.1 Physical or Sexual Abuse of Adult
V61.20 Parent-Child Relational Problem
V61.21 Sexual or Physical Abuse or Neglect of Child
V61.8 Sibling Relational Problem
V61.9 Relational Problem Related to [a Mental Disorder or General Medical Condition]
V62.2 Occupational Problem
V62.3 Academic Problem
V62.4 Acculturation Problem
V62.81 Relational Problem NOS
V62.82 Bereavement
V62.89 Phase of Life Problem
V62.89 Religious or Spiritual Problem
V62.89 Borderline Intellectual Functioning
V65.2 Malingering
V71.01 Adult Antisocial Behavior
V71.02 Child or Adolescent Antisocial Behavior
V71.09 No Diagnosis or Condition on Axis I or Axis II

Adjunctive homeopathic treatment in patients with severe sepsis: a randomized, double-blind, placebo-controlled trial in an intensive care unit

Adjunctive homeopathic treatment in patients with severe sepsis: a randomized, double-blind, placebo-controlled trial in an intensive care unit

M. Frass1, , , M. Linkesch2, S. Banyai2, 3, G. Resch1, C. Dielacher2, T. Löbl2, C. Endler1, M. Haidvogl1, I. Muchitsch1 and E. Schuster4
1 Ludwig Boltzmann Institute for Homeopathy, Graz, Austria
2 II Department of Internal Medicine, University of Vienna, Vienna, Austria
3 Cantonal Hospital of Lucerne, Switzerland
4 Department of Medical Computer Sciences, University of Vienna, Vienna, Austria
Received 3 August 2004;
revised 11 January 2005;
accepted 26 January 2005.
Available online 1 April 2011.

Background
Mortality in patients with severe sepsis remains high despite the development of several therapeutic strategies. The aim of this randomized, double-blind, placebo-controlled trial was to evaluate whether homeopathy is able to influence long-term outcome in critically ill patients suffering from severe sepsis.
Methods
Seventy patients with severe sepsis received homeopathic treatment (n=35) or placebo (n=35). Five globules in a potency of 200c were given at 12 h interval during the stay at the intensive care unit. Survival after a 30 and 180 days was recorded.
Results
Three patients (2 homeopathy, 1 placebo) were excluded from the analyses because of incomplete data. All these patients survived. Baseline characteristics including age, sex, BMI, prior conditions, APACHE II score, signs of sepsis, number of organ failures, need for mechanical ventilation, need for vasopressors or veno-venous hemofiltration, and laboratory parameters were not significantly different between groups. On day 30, there was non-statistically significantly trend of survival in favour of homeopathy (verum 81.8%, placebo 67.7%, P=0.19). On day 180, survival was statistically significantly higher with verum homeopathy (75.8% vs 50.0%, P=0.043). No adverse effects were observed.
Conclusions
Our data suggest that homeopathic treatment may be an useful additional therapeutic measure with a long-term benefit for severely septic patients admitted to the intensive care unit. A constraint to wider application of this method is the limited number of trained homeopaths.

Anxiety Screening Quiz

Use this quiz to help you determine
if you might need to see a mental health professional for diagnosis
and treatment of an anxiety or panic disorder.


Instructions: This is a screening measure to help you determine whether you might have an anxiety disorder that needs professional attention. This screening measure is not designed to make a diagnosis of an anxiety disorder or take the place of a professional diagnosis or consultation. Please take the time to fill out the below form as accurately, honestly and completely as possible.


Think back about how you've felt over the past month. Please choose how often you've experienced each of the following anxiety symptoms during that time:
Usually Often Sometimes Rarely Never
Pounding heart





Sweating





Trembling or shaking





Shortness of breath





Afraid or scared





Chest pain or discomfort





Usually Often Sometimes Rarely Never
Nausea or abdominal distress





Feeling dizzy or unsteady





Fear of losing control or going crazy





Numbness or tingling sensations





chills or hot flashes





Fear of dying





Usually Often Sometimes Rarely Never
Constant or persistent worry





Feeling of choking





Unable to relax





Feeling of being unreal





Nervous





Feeling shaky or wobbly





Usually Often Sometimes Rarely Never
Irritable or difficulty sleeping





Trembling hands





Avoid situations because of anxiety





Feeling lightheaded or faint

Sunday, May 22, 2011

The effect of the homeopathic remedies Arnica montana and Bellis perennis on mild postpartum bleeding--a randomized, double-blind, placebo-controlled

Complement Ther Med. 2005 Jun;13(2):87-90.

Oberbaum M, Galoyan N, Lerner-Geva L, Singer SR, Grisaru S, Shashar D, Samueloff A.
Source

The Center for Integrative Complementary Medicine, Shaare Zedek Medical Center, Jerusalem 91031, Israel. oberbaum@szmc.org.il
Abstract
OBJECTIVE:
To evaluate the effect of Arnica Montana and Bellis perennis on postpartum blood loss.

DESIGN:
Double blind, placebo-controlled, randomized, clinical trial.

SETTING:
Department of Gynecology, Shaare Zedek Medical Center, Jerusalem.

INTERVENTIONS:

Forty parturients were randomized to one of three groups: Arnica montana C6 and Bellis perennis C6 (n=14), Arnica montana C30 and Bellis perennis C30 (n=14), or double placebo (n=12). After 48 h the Arnica/placebo was halted, and patients continued the Bellis/placebo until cessation of lochia.
MAIN OUTCOME MEASURES:
Hemoglobin levels (Hb) at 48 and 72 h postpartum.

RESULTS:

At 72 h postpartum, mean Hb levels remained similar after treatment with homeopathic remedies (12.7 versus 12.4) as compared to a significant decrease in Hb levels in the placebo group (12.7 versus 11.6; p<0.05), in spite of less favorable initial characteristics of the treatment group. The mean difference in Hb levels at 72 h postpartum was -0.29 (95% CI -1.09; 0.52) in the treatment group and -1.18 (95% CI -1.82; -0.54) in the placebo group (p<0.05).

CONCLUSION:

Treatment with homeopathic Arnica montana and Bellis perennis may reduce postpartum blood loss, as compared with placebo.